Tissue Regenix Group plc (TRX) ORD GBP0.001
- Add to watchlist
- Create an alert
- This stock can be held in a
54.00p
n/a
74.00p
£38.47 million
54.00p
n/a
50.00p
n/a
0.00p (0.00%) Previous:
0.00p
n/a
n/a
2,000
Performance
1 week 1W | 0% | 1 year 1Y | 2.7% |
---|---|---|---|
1 month 1M | 15.63% | 2 years 2Y | 10920.41% |
3 months 3M | 18.18% | 3 years 3Y | 8540% |
6 months 6M | 12.2% | 5 years 5Y | 1536.36% |
Performance figures are based on the previous close price. Past performance is not an indication of future performance.
Fundamental data
Year ending: | 31/12/2023 | 31/12/2022 |
---|---|---|
Revenue ($m) | 29.49 | 24.48 |
Profit before tax ($m) | (1.67) | (2.83) |
Adjusted EPS (¢): | (2.43) | (3.83) |
P/E ratio | n/a | n/a |
PEG | n/a | n/a |
EPS growth (%) | n/a | n/a |
Values are quoted in the stock's local currency: US dollar
All fundamental dataDividend information for this stock is not available.
Dividend information for this stock is not available.
Ready to invest?
Important Documents
There are no documents available for this stock.
-
Tissue Regenix flags first half in line with expectations
16 July 2024 15:37
-
Tissue Regenix purchases building at Texas site
14 June 2024 09:58
-
Tissue Regenix gets approval for Irish hub, inks deal in Spain
30 October 2023 13:02
-
Hardman & Co Research on Tissue Regenix (TRX): Maiden pre-tax profit
23 September 2024 07:15
-
Interim results for the six months ended 30 June
10 September 2024 07:00
-
Grant of share options
18 July 2024 15:52
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.